Frequent EGFR exon 20 insertion in the so‐called peripheral‐type squamous cell neoplasm of uncertain malignant potential: a variant of bronchiolar adenoma or under‐recognised entity?
Histopathology · 2023
DOI: 10.1111/his.14890 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, 2023. Verfasst von Qiang Zheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Squamous Cell, Adenoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Introduction
Herein we describe a series of rare peripheral pulmonary neoplasms temporarily termed “peripheral type squamous cell neoplasm of uncertain malignant potential (PSCN‐UMP)” and investigate their relationship to bronchiolar adenoma (BA) and squamous cell carcinoma (SCC). Materials and Methods The histologic and immunohistochemical features of 10 PSCN‐UMPs and six BAs were compared. Whole exome sequencing (WES) and bioinformatics analysis were performed to further compare the genetic features of PSCN‐UMPs, BAs, and NSCLCs.
Results
All PSCN‐UMPs were peripherally located and histologically characterised by the lepidic, nested, and papillary proliferation of relatively bland squamous cells, accompanied by entrapped hyperplastic reactive pneumocytes. The basal squamous cells coexpressed TTF1 and squamous markers. Both cellular components exhibited bland morphology and a low proliferative activity. The six BAs met the morphologic and immunophenotypic features of proximal‐type BA. Genetically, driver mutations, including frequent EGFR exon 20 insertions, were found in PSCN‐UMPs, while the KRAS mutation, BRAF mutation, and ERC1::RET fusion were detected in BAs. PSCN‐UMPs also shared some alterations with BAs in mutational signatures, while copy number variants (CNV) were enriched in MET and NKX2‐1 in PSCN‐UMP and MCL1 , MECOM , SGK1 , and PRKAR1A in BA.
Conclusion
PSCN‐UMPs exhibited the proliferation of bland squamous cells accompanied by entrapped pneumocytes and frequent EGFR exon 20 insertions, which showed distinct features from BAs and SCCs. Recognition of this specific entity will help to expand the morphologic and molecular spectrum of peripheral lung squamous neoplasms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China.
- Department of Pathology, Tongji University Shanghai Pulmonary Hospital, Shanghai, China.
- Department of Pathology, Zhongshan Hospital of Fudan University, Shanghai, China.
- Department of Pathology, Jiangnan University Affiliated Hospital, Wuxi, China.
- Department of Pathology, Qingdao Municipal Hospital, Qingdao, China.
ORCID-Profile: Qiang Zheng, Likun Hou, Yue Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zheng, Q., Hou, L., Shang, G., Qi, X., Zhang, M., Jin, Y., Wang, Y., Xue, Q., Wu, C., & Li, Y. (2023). Frequent EGFR exon 20 insertion in the so‐called peripheral‐type squamous cell neoplasm of uncertain malignant potential: a variant of bronchiolar adenoma or under‐recognised entity?. Histopathology. https://doi.org/10.1111/his.14890
Vancouver
Zheng Q, Hou L, Shang G, Qi X, Zhang M, Jin Y, et al. Frequent EGFR exon 20 insertion in the so‐called peripheral‐type squamous cell neoplasm of uncertain malignant potential: a variant of bronchiolar adenoma or under‐recognised entity?. Histopathology. 2023. doi:10.1111/his.14890
BibTeX
@article{Zheng2023,
author = {Zheng, Qiang and Hou, Likun and Shang, Guoguo and Qi, Xiaowei and Zhang, Mengmeng and Jin, Yan and Wang, Yue and Xue, Qianqian and Wu, Chunyan and Li, Yuan},
title = {Frequent EGFR exon 20 insertion in the so‐called peripheral‐type squamous cell neoplasm of uncertain malignant potential: a variant of bronchiolar adenoma or under‐recognised entity?},
journal = {Histopathology},
year = {2023},
doi = {10.1111/his.14890}
}
EUVIMED